Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5return2ozma@lemmy.world to News@lemmy.world – 593 points – 3 months agofortune.com154Post a CommentPreviewYou are viewing a single commentView all commentsarticle doesnt present any pressure they are facing. also Drug production costs are often shrouded in secrecy with little clarity on how they relate to prices, if at all. Prices are never about cost, its what people are willing to pay. Which gets brutally exploited by pharmaceutical industry.To be fair, drug development is pretty expensive. A lot of the budgets for it are public-because it happens at public institutions.1 more...
article doesnt present any pressure they are facing. also Drug production costs are often shrouded in secrecy with little clarity on how they relate to prices, if at all. Prices are never about cost, its what people are willing to pay. Which gets brutally exploited by pharmaceutical industry.To be fair, drug development is pretty expensive. A lot of the budgets for it are public-because it happens at public institutions.1 more...
To be fair, drug development is pretty expensive. A lot of the budgets for it are public-because it happens at public institutions.
article doesnt present any pressure they are facing. also
Prices are never about cost, its what people are willing to pay. Which gets brutally exploited by pharmaceutical industry.
To be fair, drug development is pretty expensive. A lot of the budgets for it are public-because it happens at public institutions.